Corix Bioscience, Inc.
CXBS
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 09/30/2016 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 149.76% | -- | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4,140.95% | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -53.23% | -- | -- | ||
| Total Current Assets | 182.27% | -- | -- | ||
|
|
|||||
| Total Current Assets | 182.27% | -- | -- | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -73.94% | -- | -- | ||
| Total Assets | -58.46% | -- | -- | ||
|
|
|||||
| Total Accounts Payable | -96.89% | -- | -- | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | 170.27% | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -84.10% | -- | -- | ||
| Total Other Current Liabilities | -84.10% | -- | -- | ||
| Total Current Liabilities | -88.97% | -- | -- | ||
|
|
|||||
| Total Current Liabilities | -88.97% | -- | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 170.27% | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -76.32% | -- | -- | ||
| Total Liabilities | -80.17% | -- | -- | ||
|
|
|||||
| Common Stock & APIC | 2.34% | -- | -- | ||
| Retained Earnings | -145.48% | -- | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -45.22% | -- | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -45.22% | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -45.22% | -- | -- | ||
|
|
|||||